Rare Combined Small Cell Lung Carcinoma and Lung Squamous Cell Carcinoma Response to PD-1 Inhibitor as Third-Line Therapy: A Case Report

BACKGROUND: Combined small cell lung cancer (c-SCLC) is a relatively rare subtype of SCLC, especially when SCLC is initially diagnosed and recurrent lesions are non-small cell lung cancer (NSCLC). Moreover, SCLC combined lung squamous cell carcinoma (LUSC) has few been reported. CASE PRESENTATION: H...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhisheng, Zhang, Junling, Ge, Yunjie, Huang, Mengli, Wang, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968780/
https://www.ncbi.nlm.nih.gov/pubmed/36860892
http://dx.doi.org/10.2147/CMAR.S397711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968780/
https://www.ncbi.nlm.nih.gov/pubmed/36860892
http://dx.doi.org/10.2147/CMAR.S397711

Ejemplares similares